Vivesto Stock

Vivesto Div.-Adj. PEG

Dividend-Adjusted PEG Ratio of Vivesto (VIVE.ST) as of Aug 12, 2026.

Div.-Adj. PEG

0.00

Last updated:

Dividend-Adjusted PEG Ratio of Vivesto is 2026 0.00 . Dividend-Adjusted PEG Ratio of Vivesto was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

On Eulerpool you can find the complete historical development of Dividend-Adjusted PEG Ratio Vivesto since 2006 – with annual values, charts, and detailed analysis.

The dividend-adjusted PEG ratio factors in dividend yield alongside earnings growth, providing a more complete valuation for income-paying stocks.

To evaluate Dividend-Adjusted PEG Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Dividend-Adjusted PEG Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Dividend-Adjusted PEG Ratio's Vivesto with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vivesto

All Key Metrics — Vivesto